Results 81 to 90 of about 221,229 (313)

Phosphoinositides and inositol phosphates as molecular glues

open access: yesFEBS Letters, EarlyView.
Inositol phosphates (IPs) and phosphoinositides (PIPs) regulate diverse eukaryotic processes. Beyond recruiting signaling proteins or acting as structural cofactors, recent studies suggest they mediate protein–protein interactions as natural molecular glues.
Aleshia Seaton‐Terry   +9 more
wiley   +1 more source

Types of licensed child care in Oregon. Vietnamese

open access: yes, 2016
"LIC-311vn 4/5/2016."Includes list of situations when child care providers are not required to be licensed.This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program.

core  

Three phosphatase families form a community: The phosphohydrolases that act upon inositol pyrophosphates

open access: yesFEBS Letters, EarlyView.
Inositol pyrophosphates are energy‐rich signaling molecules that perform critical functions in cells. Three different families of phosphatases hydrolyze the β phosphate of the inositol pyrophosphate molecules: two have narrow specificities and one is promiscuous.
Ronda J. Rolfes
wiley   +1 more source

Types of licensed child care in Oregon. Chinese

open access: yes, 2016
"LIC-311ch 4/5/2016."Includes list of situations when child care providers are not required to be licensed.This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program.

core  

Does citation matter? Research citation in policy documents as an indicator of research impact – an Australian obesity policy case-study

open access: yesHealth Research Policy and Systems, 2018
Background Citation of research in policy documents has been suggested as an indicator of the potential longer-term impacts of research. We investigated the use of research citations in childhood obesity prevention policy documents from New South Wales ...
Robyn Newson   +4 more
doaj   +1 more source

ABL kinase‐dependent phosphorylation of SH proteins promotes their direct interaction with CRK family SH2 domains

open access: yesFEBS Letters, EarlyView.
CT10 regulator of kinase (CRK) and CRK‐Like (CRKL) are signaling adaptors driving cell adhesion, motility, differentiation, and proliferation. SH2‐domain containing (SH) proteins are enriched in YXXP motifs which when phosphorylated create preferred binding sites for CRK family SH2 domains.
Phoebe M. Cousens   +8 more
wiley   +1 more source

Types of licensed child care in Oregon. Spanish

open access: yes, 2016
"LIC-311sp 4/5/2016."Includes list of situations when child care providers are not required to be licensed.This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program.

core  

The role of miR‐335‐5p in the redifferentiation of BRAF p.V600E thyroid cancers

open access: yesMolecular Oncology, EarlyView.
The BRAF p.V600E mutation promotes thyroid cancer dedifferentiation and radioiodine resistance. Using a network approach, we identified miR‐335‐5p as a key regulator of BRAF‐mutated thyroid tumors. Restoring miR‐335‐5p increased thyroid‐specific gene expression and iodine uptake in cells and organoids.
Valeria Pecce   +11 more
wiley   +1 more source

Types of licensed child care in Oregon. Russian

open access: yes, 2016
"LIC-311ru 4/5/2016."Includes list of situations when child care providers are not required to be licensed.This archived document is maintained by the State Library of Oregon as part of the Oregon Documents Depository Program.

core  

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

open access: yesMolecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy